Send us a text World Heart Federation host Shreya Shrikhande speaks with Mike Lane from the Amyloidosis Army and David Gregory from the Amyloidosis Alliance on their powerful journeys with ATTR-CM. They share the challenges of misdiagnosis, treatment access, community support, and the urgent need for awareness and early detection of transthyretin amyloid cardiomyopathy. Find out more about Transthyretin Amyloid Cardiomyopathy ATTR-CM on World Heart Federation website.
All content for World Heart Podcasts is the property of World Heart Federation and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text World Heart Federation host Shreya Shrikhande speaks with Mike Lane from the Amyloidosis Army and David Gregory from the Amyloidosis Alliance on their powerful journeys with ATTR-CM. They share the challenges of misdiagnosis, treatment access, community support, and the urgent need for awareness and early detection of transthyretin amyloid cardiomyopathy. Find out more about Transthyretin Amyloid Cardiomyopathy ATTR-CM on World Heart Federation website.
Global Heart Podcast: 2025 WHO Guidelines on Low Sodium Salt Substitutes
World Heart Podcasts
48 minutes
7 months ago
Global Heart Podcast: 2025 WHO Guidelines on Low Sodium Salt Substitutes
Send us a text In this episode, we explore the 2025 WHO guidelines on the use of low-sodium salt substitutes. Prof. Mary L’Abbé, a member of the WHO guideline development group, explains the evidence, recommendations, and key considerations behind this important new guideline. Later, Prof. Jaime Miranda reflects on the global public health implications, implementation challenges, and how salt substitution could be a game changer for reducing population-level cardiovascular risk. Tune in to le...
World Heart Podcasts
Send us a text World Heart Federation host Shreya Shrikhande speaks with Mike Lane from the Amyloidosis Army and David Gregory from the Amyloidosis Alliance on their powerful journeys with ATTR-CM. They share the challenges of misdiagnosis, treatment access, community support, and the urgent need for awareness and early detection of transthyretin amyloid cardiomyopathy. Find out more about Transthyretin Amyloid Cardiomyopathy ATTR-CM on World Heart Federation website.
